Clinical Strength Ocu Support

Clinical Strength Ocu Support

Protocol For Life Balance4.8 (113 ratings)
Format:Capsule Quantity: 90 Capsule(s) · 30 servings
Goals
$35.00 $1.16 per serving

Product analysis

49 out of 100

Clinical Strength Ocu Support supplies lutein for the eye pigment involved in filtering blue light, alongside nutrients that can help fill dietary gaps. Its mixed formula should not be assumed to improve everyday vision or match combinations used for specific eye conditions.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality37

Natural vitamin E and the named chromium form are strengths of the ingredient selection. Several other forms are unspecified or cannot be compared confidently, leaving the quality picture incomplete.

Ingredient Transparency71

All ingredient amounts are disclosed, and many forms are named. Missing forms and the undisclosed proportions of the ginkgo components make some preparation comparisons difficult.

Value For Money37

Value is limited for several ingredients, particularly riboflavin, chromium and CoQ10. Vitamin A and rutin offer more moderate value, while several other contributions remain uncertain.

Customer Satisfaction74

Customer feedback is strongly positive. The relatively small review base is useful buying context, without proving eye-health effects.

Product Focus37

Eye health is the clearest purpose, led by lutein and supporting nutrients. The extensive mix makes it harder to tell which additional ingredients meaningfully contribute.

Format
Capsule
Container
90 Capsule(s)
Per serving
$1.16
Customer rating
4.8 · 113 ratings
Report analysis

Goals

Impact
High effect
D+ Ingredient FitB+ PathwaysA+ EvidenceA Formulation Logic
Zinc · 7.5 mgVitamin E · 100 IUVitamin C · 250 mgVitamin A · 10000 IU

Declared lutein relates to macular pigment and blue-light filtering, with the amount contributing to the saved finding. Vitamin C and other antioxidant nutrients have evidence within a defined combination for selected people with age-related macular degeneration, rather than general visual improvement. Vitamin A also supports the visual cycle when intake is inadequate. Bilberry benefits depend on a specific studied extract, so generic or unresolved bilberry cannot inherit them.

How this product is rated for Eye Health

Ingredient fit53

Recognized vision ingredients contribute within the selected serving, with the broader formula and amount findings determining its focus.
Goal fit
Recognized vision-related ingredients sit within a broader formula that also serves other purposes.
Dose adequacy
The selected serving provides partial or uneven amounts across the recognized ingredients, limiting the saved amount finding.

Pathways80

The strongest saved mechanism coverage concerns retinal and lens antioxidant defense; this does not establish improved clinical vision.
Depth
The strongest saved mechanism coverage concerns retinal and lens antioxidant defense; this does not establish improved clinical vision.
Breadth
The saved coverage threshold is reached for macular pigment and blue-light filtering, retinal and lens antioxidant defense.

Evidence100

carotenoids leads the saved evidence finding, although the supplied context limits how confidently routine vision benefits can be expected.
Evidence strength
carotenoids leads the saved evidence finding, although the supplied context limits how confidently routine vision benefits can be expected.
Studied preparation
The recognized preparations meet the saved preparation criteria; this does not mean the finished product has demonstrated visual improvement.

Formulation logic92

No unmet partner requirement or configured conflict was identified; only the ingredients meeting the saved amount threshold count here.
Partner coverage
The recognized ingredients have no unmet partner requirement in the saved findings; this does not establish synergy.
Conflicts
No configured ingredient conflict was identified; this finding does not establish overall safety.
Effective doses
Some ingredients fall below the saved minimum amount threshold or have unresolved amounts, limiting their contribution.
Study evidence
Ginkgo Supportive 11 studies
Riboflavin Supportive 69 studies
Rutin Not classified 1 study
Selenium Supportive 15 studies
Taurine Supportive 1 study
Vitamin A Supportive 65 studies
Vitamin C Disputed 24 studies
Vitamin E Disputed 35 studies
Zinc Supportive 39 studies
Impact
High effect
D+ Ingredient FitD+ PathwaysA+ EvidenceA Formulation Logic
Zinc · 7.5 mgVitamin C · 250 mgSelenium · 50 mcgGreen Tea · 50 mgVitamin E · 100 IU

Lutein has limited support for selected skin-tone and UV-response outcomes, but this serving's zeaxanthin amount differs from the studied combination. Vitamin C, zinc, riboflavin and B6 can support skin when their intake is low, without established extra benefit in adequately nourished adults. Vitamin A and E retain IU declarations but lack resolved amounts for this calculation.

How this product is rated for Skin Health

Ingredient fit53

Lutein and several nutrients provide relevant connections, with unresolved vitamin A and E amounts and several low-level ingredients.
Goal fit
The recognized ingredients provide a focused connection to skin, although links to other goals also affect focus.
Dose adequacy
Amount recognition is limited by unresolved vitamin A and E quantities and partial recognition for several nutrients.

Pathways51

The recognized contribution centers on UV antioxidant defence, with no recognized hydration, barrier-lipid or collagen-matrix coverage.
Depth
UV antioxidant defence is the strongest recognized pathway.
Breadth
Coverage is concentrated in UV antioxidant defence rather than spread across skin hydration, barrier and structure.

Evidence100

Vitamin C leads the saved evidence finding. Its skin relevance remains limited by the specific population, preparation or nutritional conditions described.
Evidence strength
Vitamin C has the strongest recognized evidence, chiefly for its essential function and deficiency-related skin problems.
Studied preparation
The saved finding recognizes the eligible preparations; this does not remove the supplied context's population, composition or outcome limitations.

Formulation logic94

No required partner is missing and no assessed conflict is recorded. Unresolved vitamin A and E amounts limit the amount finding.
Partner coverage
The recognized ingredients do not require an additional missing partner; no extra combination benefit is established.
Conflicts
No assessed conflict is recorded; this does not establish comprehensive interaction testing.
Effective doses
Vitamin A and E lack resolved amounts; the other counted ingredients meet the saved minimum amount criterion.
Study evidence
Green Tea Supportive 37 studies
Selenium Supportive 22 studies
Vitamin A Supportive 106 studies
Vitamin C Supportive 53 studies
Vitamin E Supportive 38 studies
Zinc Supportive 66 studies
Inflammation
Impact
Lower effect
F Ingredient FitF PathwaysA- EvidenceA Formulation Logic
Coenzyme Q-10 · 10 mgVitamin E · 100 IUTaurine · 50 mgVitamin C · 250 mgGreen Tea · 50 mgGlutathione · 2.5 mg
Study evidence
Rutin Supportive 6 studies
Selenium Supportive 34 studies
Taurine Supportive 12 studies
Vitamin C Supportive 50 studies
Vitamin E Supportive 20 studies
Zinc Supportive 64 studies

Ingredients

IngredientAmount per servingScore
Vitamin A (Beta-Carotene)
10000 IU 63
Vitamin C (Ascorbic Acid)
250 mg
Vitamin E (D-Alpha-Tocopheryl Succinate)
100 IU 60
Riboflavin
15 mg 40
Vitamin B6 (Pyridoxine Hydrochloride)
10 mg
Vitamin B12 (Methylcobalamin)
100 mcg 59
Zinc (L-OptiZinc Zinc-L-Methionine)
7.5 mg
Selenium (SelenoPure L-Selenomethionine)
50 mcg
Chromium (Chromemate Chromium Polynicotinate)
50 mcg 48
Citrus Bioflavonoid Complex
100 mg
Rutin powder (Sophora japonica)
100 mg 83
Eyebright
100 mg
Green Tea extract
50 mg 24
Taurine
50 mg 46
N-Acetyl Cysteine
50 mg
Bilberry extract (Total Anthocyanins)
25 mg
Alpha Lipoic Acid
25 mg
Grape seed extract (Polyphenols)
25 mg
Ginkgo biloba extract (Ginkgoflavonglycosides, Terpene Lactones)
20 mg
CoQ10 (Ubiquinone)
10 mg 42
Lutein (FloraGLO Marigold flowers extract)
10 mg
Zeaxanthin (FloraGLO Marigold flowers extract)
500 mcg
L-Glutathione
2.5 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
A+ Composition And Label DisclosureD+ Commercial Price And Usability
Each serving lists 100 mg of active rutin. The whole-product price works out to about $1.17 per 100 mg of declared rutin preparation, an estimate that assigns the entire product cost to rutin.
How this ingredient is rated

Composition and Label Disclosure

No separate composition assessment was performed for rutin.

Composition and Label Disclosure100

The active rutin amount is specified as 100 mg per serving.
Declared Active Rutin Amount
The active rutin amount is recorded as 100 mg per serving.

Commercial Price and Usability50

The estimated whole-product cost is about $1.17 per 100 mg of declared rutin preparation.
Whole-Product Cost per 100 mg Declared Rutin Preparation
The whole-product price is approximately $1.17 per 100 mg of declared rutin preparation; this estimate does not establish active rutin yield.
D+ Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyD+ Value
A serving supplies 10,000 IU of vitamin A, all identified as beta-carotene. The whole serving costs about $1.17.
How this ingredient is rated

Active Ingredient Quality & Bioavailability50

All of the vitamin A is identified as beta-carotene, a provitamin A source.
Vitamin A Chemical Form & Source
All of the vitamin A is identified as beta-carotene, a provitamin A source.

Dose, Safety & Label Transparency83

A serving supplies 10,000 IU of vitamin A. The label explicitly identifies 100% of the vitamin A as beta-carotene.
Dosage Efficacy & Safety Thresholds
A serving supplies 10,000 IU of vitamin A.
Label Transparency of Specific Forms
The label explicitly identifies 100% of the vitamin A as beta-carotene.

Value50

The cost works out to about $0.58 per 5,000 IU of vitamin A, based on the whole-product serving price.
Price per 5,000 IU Dose
The cost works out to about $0.58 per 5,000 IU of vitamin A, based on the whole-product serving price.
D Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyD- Value
A serving provides 100 IU of vitamin E as d-alpha-tocopheryl succinate, a natural form. The whole product costs about $1.17 per serving.
How this ingredient is rated

Active Ingredient Quality & Bioavailability46

The vitamin E is identified as d-alpha-tocopheryl succinate, a natural form. The saved facts do not establish mixed tocopherols or tocotrienols.
Natural (d-alpha) vs. Synthetic (dl-alpha)
D-Alpha-Tocopheryl Succinate is a natural form of vitamin E.
Mixed Tocopherol Isomer Diversity
The saved facts do not establish a mixed-tocopherol complex.
Tocotrienol Complex Inclusion
The saved facts do not establish the presence of tocotrienols.

Dose, Safety & Label Transparency85

A serving provides 100 IU of vitamin E. The amount and d-alpha-tocopheryl succinate form are named; individual isomer milligram amounts are not established.
Therapeutic Dosage Range
A serving provides 100 IU of vitamin E.
Label Transparency and Isomer Specificity
The amount and d-alpha-tocopheryl succinate form are named; individual isomer milligram amounts are not established.

Value40

A whole-product serving costs about $1.17; the identified forms are d-prefixed.
Cost per Natural-Form Therapeutic Serving
A whole-product serving costs about $1.17; the identified forms are d-prefixed.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsEye Health forGinkgo
  2. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsEye Health forGinkgo
  3. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsEye Health forGinkgo
  4. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsEye Health forGinkgo
  5. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsEye Health forGinkgo
  6. U.S. Multicenter Clinical Trial of Corneal Collagen Crosslinking for Treatment of Corneal Ectasia after Refractive Surgery.
    Hersh PS; Stulting RD; Muller D; Durrie DS; Rajpal RK; U.S. Crosslinking Study Group · Ophthalmology · 2017
    Randomized trial179 participantsEye Health forRiboflavin
  7. United States Multicenter Clinical Trial of Corneal Collagen Crosslinking for Keratoconus Treatment.
    Hersh PS; Stulting RD; Muller D; Durrie DS; Rajpal RK; United States Crosslinking Study Group · Ophthalmology · 2017
    Randomized trial205 participantsEye Health forRiboflavin
  8. EpiSmart Crosslinking for Keratoconus: A Phase 2 Study.
    Epstein RJ; Belin MW; Gravemann D; Littner R; Rubinfeld RS · Cornea · 2023
    Randomized trial2,228 participantsEye Health forRiboflavin
  9. Prospective Randomized Trial of Corneal Cross-linking Riboflavin Dosing Frequencies for Treatment of Keratoconus and Corneal Ectasia.
    Price MO; Fairchild K; Feng MT; Price FW · Ophthalmology · 2019
    Randomized trial510 participantsEye Health forRiboflavin
  10. Corneal collagen cross-linking for keratoconus: results of 3-year follow-up in Pakistani population.
    Khan WA; Zaheer N; Khan S · Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2015
    Non-randomized trial66 participantsEye Health forRiboflavin
  11. A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin
    Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM · American Journal of Ophthalmology · 1994
    Randomized trial53 participantsEye Health forRutin
  12. Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial.
    Watson SL; Jones LW; Stapleton F; Hinds M; Ng A; Tan J; Alster Y; Bosworth C; Rafaeli O; DePuy V; CELESTIAL STUDY Group · The ocular surface · 2026
    Randomized trial245 participantsEye Health forSelenium
  13. The efficacy and safety of selenium supplementation versus placebo in the treatment of Graves' orbitopathy: A systematic review and meta-analysis of randomised controlled trials.
    Sharabati I; Qafesha RM; Hindawi MD; Amro S; Ayesh BM · Clinical endocrinology · 2024
    Meta-analysis4 studies pooledEye Health forSelenium
  14. Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction over six months of treatment: A Phase 2, vehicle-controlled, randomized extension trial.
    Downie LE; Craig JP; Stapleton F; Tan J; Jones LW; Ng A; Hinds M; Bosworth C; Alster Y · The ocular surface · 2025
    Randomized trial245 participantsEye Health forSelenium
  15. AZR-MD-001 0.5% selenium sulfide ophthalmic ointment for the treatment of contact lens discomfort: A vehicle-controlled, randomized, clinical trial.
    Stapleton F; Hinds M; Tan J; Jones L; Chalmers R; Bosworth C; Alster Y · The ocular surface · 2025
    Randomized trial67 participantsEye Health forSelenium
  16. The effect of a biweekly novel selenium sulfide-containing topical treatment in symptomatic contact lens wearers: An exploratory study.
    Stapleton F; Jia T; DePuy V; Bosworth C; Gleeson M; Tan J · The ocular surface · 2025
    Randomized trial14 participantsEye Health forSelenium
  17. Effects of taurine supplementation on VDT work induced visual stress.
    Zhang M; Bi LF; Ai YD; Yang LP; Wang HB; Liu ZY; Sekine M; Kagamimori S · Amino acids · 2005
    Randomized trial25 participantsEye Health forTaurine
  18. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
    Berson EL; Rosner B; Sandberg MA; Hayes KC; Nicholson BW; Weigel-DiFranco C; Willett W · Archives of ophthalmology (Chicago, Ill. : 1960) · 1993
    Randomized trial601 participantsEye Health forVitamin A
  19. Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial.
    Toshida H; Funaki T; Ono K; Tabuchi N; Watanabe S; Seki T; Otake H; Kato T; Ebihara N; Murakami A · Drug design, development and therapy · 2018
    Randomized trial66 participantsEye Health forVitamin A
  20. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.
    Imdad A; Mayo-Wilson E; Haykal MR; Regan A; Sidhu J; Smith A; Bhutta ZA · The Cochrane database of systematic reviews · 2022
    Meta-analysis1,223,856 participants47 studies pooledEye Health forVitamin A